お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989729

前臨床CROの市場動向・市場シェア・市場規模の予測 (2021-2028年):サービス (毒性試験・バイオアナリシス・DMPK研究)・エンドユーザー (バイオ医薬品企業・政府&学術機関)・地域別

Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 240 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
前臨床CROの市場動向・市場シェア・市場規模の予測 (2021-2028年):サービス (毒性試験・バイオアナリシス・DMPK研究)・エンドユーザー (バイオ医薬品企業・政府&学術機関)・地域別
出版日: 2021年02月11日
発行: Grand View Research, Inc.
ページ情報: 英文 240 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前臨床CROの市場規模は予測期間中8.1%のCAGRで推移し、2028年には84億米ドルの規模に成長すると予測されています。R&D費の増加、アウトソーシングの増加などの要因が同市場の成長を推進しています。また、前臨床段階に入る新薬の増加も予測期間中の市場成長を後押しする見通しです。

当レポートでは、世界の前臨床CROの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、製品パイプラインの分析、市場規模の推移・予測、サービス・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の見通し
  • 普及・成長の見通しマッピング
  • 製品パイプライン分析
  • 市場力学
  • 市場分析ツール

第4章 市場予測・動向分析:サービス別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • バイオアナリシス・DMPK研究
  • 毒性試験
  • その他

第5章 市場予測・動向分析:エンドユーザー別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • バイオ医薬品企業
  • 政府・学術機関
  • 医療機器企業

第6章 市場予測・動向分析:地域・主要国別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • ベルギー
    • スイス
    • ロシア
    • スウェーデン
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • マレーシア
    • インドネシア
    • シンガポール
    • フィリピン
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • エジプト

第7章 競合分析

  • 企業プロファイル
    • Envigo Corporation
    • MPI research
    • Eurofins Scientific
    • PRA Health Sciences, Inc
    • Wuxi AppTec
    • Medpace, Inc.
    • Pharmaceutical Product Development (PPD), LLC
    • PARAXEL International Corporation
    • ICON Plc.
    • Laboratory Corporation of America, Inc.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Preclinical CRO Market, By Region, 2016 - 2028 (USD Million)
  • Table 4 Global Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 5 Global Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 6 North America Preclinical CRO Market, By Country, 2016 - 2028 (USD Million)
  • Table 7 North America Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 8 North America Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 9 U.S. Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 10 U.S. Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 11 Canada Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 12 Canada Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 13 Europe Preclinical CRO Market, By Country, 2016 - 2028 (USD Million)
  • Table 14 Europe Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 15 Europe Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 16 U.K. Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 17 U.K. Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 18 Germany Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 19 Germany Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 20 France Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 21 France Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 22 Italy Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 23 Italy Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 24 Spain Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 25 Spain Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 26 Netherlands Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 27 Netherlands Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 28 Belgium Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 29 Belgium Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 30 Switzerland Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 31 Switzerland Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 32 Russia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 33 Russia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 34 Sweden Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 35 Sweden Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 36 Asia Pacific Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 37 Asia Pacific Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 38 China Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 39 China Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 40 Japan Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 41 Japan Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 42 India Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 43 India Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 44 Australia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 45 Australia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 46 South Korea Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 47 South Korea Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 48 Malaysia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 49 Malaysia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 50 Indonesia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 51 Indonesia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 52 Singapore Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 53 Singapore Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 54 Philippines Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 55 Philippines Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 56 Thailand Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 57 Thailand Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 58 Latin America Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 59 Latin America Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 60 Brazil Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 61 Brazil Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 62 Mexico Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 63 Mexico Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 64 Argentina Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 65 Argentina Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 66 Colombia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 67 Colombia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 68 Chile Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 69 Chile Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 70 Middle East & Africa Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 71 Middle East & Africa Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 72 South Africa Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 73 South Africa Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 74 Saudi Arabia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 75 Saudi Arabia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 76 UAE Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 77 UAE Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 78 Israel Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 79 Israel Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
  • Table 80 Egypt Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
  • Table 81 Egypt Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Preclinical CRO Market: Market snapshot
  • Fig. 9 Preclinical CRO Market: Market segmentation
  • Fig. 10 Preclinical CRO Market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Preclinical CRO Market driver impact
  • Fig. 14 Preclinical CRO Market restraint impact
  • Fig. 15 Preclinical CRO Market porter's five forces analysis
  • Fig. 16 Preclinical CRO Market PESTEL analysis
  • Fig. 17 Preclinical CRO Market segment dashboard
  • Fig. 18 Preclinical CRO Market: Service movement Analysis
  • Fig. 19 Bioanalysis and DMPK studies market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 20 Toxicology testing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 22 Preclinical CRO Market segment dashboard
  • Fig. 23 Preclinical CRO Market: End-use Movement Analysis
  • Fig. 24 Biopharmaceutical companies market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 25 Government and academic institutes market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 26 Medical device companies market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 27 Global Preclinical CRO Market: Regional movement analysis
  • Fig. 28 Global Preclinical CRO Market: Regional Outlook and key takeaways
  • Fig. 29 Global market share, by region
  • Fig. 30 North America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 31 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 32 Canada market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 33 Europe market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 34 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 35 Germany market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 36 France market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 37 Italy market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 38 Spain market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 39 Netherlands market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 40 Belgium market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 41 Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 42 Russia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 43 Sweden market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 45 China market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 46 Japan market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 47 India market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 48 Australia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 49 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 50 Malaysia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 51 Indonesia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 52 Singapore market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 53 Philippines market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 54 Thailand market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 55 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 56 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 57 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 58 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 59 Colombia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 60 Chile market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 62 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 63 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 64 UAE market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 65 Israel market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 66 Egypt market estimates and forecast, 2016 - 2028 (USD Million)
目次
Product Code: GVR-2-68038-035-4

Preclinical CRO Market Growth & Trends

The global preclinical CRO market size is expected to reach USD 8.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The market is expected to witness lucrative growth over the forecast period due to increasing R&D expenditure and growing outsourcing trend. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market growth over the forecast period.

The market is undergoing a series of mergers and acquisitions, resulting in the improvement in full-service capabilities and international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, mid-sized and smaller contract research organizations (CROs) are focusing on niche sectors and are providing a personalized approach to their sponsors. Various companies are focusing on research and development of new drugs, and therefore are outsourcing these activities to launch efficient CRO services in the market. This, in turn, provides a positive atmosphere for joint ventures among market participants owing to the preference of sponsors to maximize their benefits.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 20, 2021, more than 96.7 million cases of COVID-19 were reported globally, with more than 2,068,303 deaths across the globe. This pandemic has fast-tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in preclinical studies as well as trials.

North America held the largest share of 47.7% in 2020. Significant investment in healthcare R&D, coupled with well-developed healthcare infrastructure in the U.S., is contributing to the largest share of North America. Asia Pacific is projected to expand at the fastest CAGR of 12.0% over the forecast period.

Preclinical CRO Market Report Highlights

  • By service, the toxicology testing segment accounted for the largest share of 61.1% in 2020 due to its significance in Investigational New Drug (IND)-enabling studies
  • Based on end-use, the government and academic institutes segment is anticipated to register the highest CAGR of 8.4% over the forecast period due to improving government initiatives toward healthcare, especially in developing economies
  • North America dominated the market in 2020 with a share of 47.7%. Significant healthcare expenditure on R&D is one of the major factors driving the market in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Service
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Preclinical CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis, by Service
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Surging number of drugs in preclinical phases
      • 3.4.1.2. Economies of production and scale
      • 3.4.1.3. Increasing R&D expenditure
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. High labor cost
      • 3.4.2.2. Stringent regulatory policies
    • 3.4.3. Industry Challenges
      • 3.4.3.1. Managing the relationships
  • 3.5. Preclinical CRO: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Preclinical CRO Market: Segment Analysis, by Service, 2016 - 2028 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2020 & 2028
  • 4.3. Segment Dashboard
  • 4.4. Global Preclinical CRO Market, by service, 2016 to 2028
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 4.5.1. Bioanalysis and DMPK studies
    • 4.5.2. Toxicology testing
    • 4.5.3. Others

Chapter 5. Preclinical CRO Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. End-use market share analysis, 2020 & 2028
  • 5.3. Segment Dashboard
  • 5.4. Global Preclinical CRO market, by end use, 2016 to 2028
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 5.5.1. Biopharmaceutical companies
    • 5.5.2. Government and academic institutes
    • 5.5.3. Medical device companies

Chapter 6. Preclinical CRO Market: Regional Market Analysis, By Service, End Use, 2016 - 2028 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional Market Share Analysis, 2020 & 2028
  • 6.3. Regional Market Dashboard
  • 6.4. Regional Market Snapshot
  • 6.5. Regional Market Share, 2018
  • 6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.7.2. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.7.3. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.7.4. U.S.
      • 6.7.4.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.7.5. Canada
      • 6.7.5.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.8.2. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.8.3. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.4. Germany
      • 6.8.4.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.5. U.K.
      • 6.8.5.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.6. France
      • 6.8.6.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.7. Italy
      • 6.8.7.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.8. Spain
      • 6.8.8.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.9. Netherlands
      • 6.8.9.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.9.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.10. Belgium
      • 6.8.10.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.10.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.11. Switzerland
      • 6.8.11.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.11.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.12. Russia
      • 6.8.12.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.12.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.8.13. Sweden
      • 6.8.13.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.8.13.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.9.2. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.9.3. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.4. China
      • 6.9.4.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.5. Japan
      • 6.9.5.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.6. India
      • 6.9.6.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.7. Australia
      • 6.9.7.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.8. South Korea
      • 6.9.8.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.9.8.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.9. Malaysia
      • 6.9.9.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.9.9.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.10. Indonesia
    • 6.9.11. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.9.12. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.13. Singapore
    • 6.9.14. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.9.15. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.16. Philippines
    • 6.9.17. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.9.18. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.9.19. Thailand
    • 6.9.20. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.9.21. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
  • 6.10. Latin America
    • 6.10.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.10.2. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.10.3. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.10.4. Brazil
      • 6.10.4.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.10.4.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.10.5. Mexico
      • 6.10.5.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.10.5.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.10.6. Argentina
      • 6.10.6.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.10.6.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.10.7. Colombia
      • 6.10.7.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.10.7.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.10.8. Chile
      • 6.10.8.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.10.8.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
  • 6.11. Middle East and Africa
    • 6.11.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.11.2. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
    • 6.11.3. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.11.4. South Africa
      • 6.11.4.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.11.4.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.11.5. Saudi Arabia
      • 6.11.5.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.11.5.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.11.6. UAE
      • 6.11.6.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.11.6.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.11.7. Israel
      • 6.11.7.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.11.7.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)
    • 6.11.8. Egypt
      • 6.11.8.1. Market estimates and forecast, by Service, 2016 - 2028 (USD Million)
      • 6.11.8.2. Market estimates and forecast, by End Use, 2016 - 2028 (USD Million)

Chapter 7. Preclinical CRO Market - Competitive Analysis

  • 7.1. Key companies profiled
    • 7.1.1. Envigo Corporation
      • 7.1.1.1. Company Overview
      • 7.1.1.2. Financial Performance
      • 7.1.1.3. Product Benchmarking
      • 7.1.1.4. Strategic Initiatives
    • 7.1.2. MPI research
      • 7.1.2.1. Company Overview
      • 7.1.2.2. Financial Performance
      • 7.1.2.3. Product Benchmarking
      • 7.1.2.4. Strategic Initiatives
    • 7.1.3. Eurofins Scientific
      • 7.1.3.1. Company Overview
      • 7.1.3.2. Financial Performance
      • 7.1.3.3. Product Benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. PRA Health Sciences, Inc
      • 7.1.4.1. Company Overview
      • 7.1.4.2. Financial Performance
      • 7.1.4.3. Product Benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. Wuxi AppTec
      • 7.1.5.1. Company Overview
      • 7.1.5.2. Financial Performance
      • 7.1.5.3. Product Benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. Medpace, Inc.
      • 7.1.6.1. Company Overview
      • 7.1.6.2. Financial Performance
      • 7.1.6.3. Product Benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. Pharmaceutical Product Development (PPD), LLC
      • 7.1.7.1. Company Overview
      • 7.1.7.2. Financial Performance
      • 7.1.7.3. Product Benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. PARAXEL International Corporation
      • 7.1.8.1. Company Overview
      • 7.1.8.2. Financial Performance
      • 7.1.8.3. Product Benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. ICON Plc.
      • 7.1.9.1. Company Overview
      • 7.1.9.2. Financial Performance
      • 7.1.9.3. Product Benchmarking
      • 7.1.9.4. Strategic Initiatives
    • 7.1.10. Laboratory Corporation of America, Inc.
      • 7.1.10.1. Company Overview
      • 7.1.10.2. Financial Performance
      • 7.1.10.3. Product Benchmarking
      • 7.1.10.4. Strategic Initiatives 
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.